BRIEF published on 06/16/2026 at 10:10, 27 days 12 hours ago Giorgio Bargiani Wins Prestigious Bartending Award Mixology Europe's 50 Best Bars Giorgio Bargiani Connaught Bar Altos Bartenders' Bartender Award
BRIEF published on 06/16/2026 at 10:10, 27 days 12 hours ago Giorgio Bargiani remporte un prestigieux prix de barman Mixologie Les 50 Meilleurs Bars D'Europe Giorgio Bargiani Connaught Bar Prix Altos Des Barmans
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago Shell Recharge and SINEXCEL Open Joint Innovation Lab for EV Charging Sustainable Energy EV Charging Innovation Lab Shell Recharge SINEXCEL Partnership
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago Shell Recharge et SINEXCEL ouvrent un laboratoire d'innovation commun pour la recharge des véhicules électriques Énergie Durable Laboratoire D'innovation Recharge Des Véhicules Électriques Recharge Shell Partenariat SINEXCEL
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago S&P Upgrades BarmeniaGothaer Ratings to “A+”, Outlook Stable S&P Global Ratings Rating Upgrade Financial Stability BarmeniaGothaer Insurance Merger
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago S&P relève la notation de BarmeniaGothaer à « A+ », perspective stable S&P Global Ratings Stabilité Financière BarmeniaGothaer Amélioration De La Notation Fusion D'assurances
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago PL BioScience Welcomes Maik W. Jornitz to Board of Directors Board Of Directors Biopharmaceutical Growth Human Platelet Lysate PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:05, 27 days 12 hours ago PL BioScience accueille Maik W. Jornitz au sein de son conseil d'administration. Conseil D'administration Croissance Biopharmaceutique Lysat Plaquettaire Humain PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:00, 27 days 12 hours ago Innovative Molecules Advances with New EBV Antiviral Program Clinical-stage Innovative Molecules EBV Virology Pipeline Antiviral Program
BRIEF published on 06/16/2026 at 10:00, 27 days 12 hours ago Des molécules innovantes progressent grâce à un nouveau programme antiviral contre le virus d'Epstein-Barr Stade Clinique Molécules Innovantes EBV Pipeline De Virologie Programme Antiviral
Published on 07/13/2026 at 21:35, 1 hour 16 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 2 hours 51 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 19:30, 3 hours 21 minutes ago NioCorp to Appear on CNBC's "Squawk Box Asia" Program Today at 8:30 p.m. ET
Published on 07/13/2026 at 15:27, 7 hours 24 minutes ago As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
Published on 07/13/2026 at 15:10, 7 hours 41 minutes ago iFabric Corp. Announces Launch of Aura Scrubs at U.S. National Mass Retailer
Published on 07/13/2026 at 22:30, 21 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 1 hour 31 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 1 hour 34 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 2 hours 3 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 2 hours 28 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 4 hours 51 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 4 hours 51 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 4 hours 51 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
